Abstract
In the last years, there are more and more reports published in prestigious journals addressing the successful application of essential oils for the eradication or prevention of microbial biofilms. Moreover, by combining the unique properties of nanoparticles with the antimicrobial activity of the essential oils, functionalized surfaces with an improved resistance to microbial colonization and biofilm development were obtained. These results may represent an interesting option for the medical field, opening new directions for the design of modified surfaces with desired and controlled anti-biofilm properties.
Keywords: Microbial biofilms, Candida albicans, Quorum sensing, Magnetite, Nanobiosystems
Current Organic Chemistry
Title:Essential Oils and Nanotechnology for Combating Microbial Biofilms
Volume: 17 Issue: 2
Author(s): Alexandru M. Grumezescu
Affiliation:
Keywords: Microbial biofilms, Candida albicans, Quorum sensing, Magnetite, Nanobiosystems
Abstract: In the last years, there are more and more reports published in prestigious journals addressing the successful application of essential oils for the eradication or prevention of microbial biofilms. Moreover, by combining the unique properties of nanoparticles with the antimicrobial activity of the essential oils, functionalized surfaces with an improved resistance to microbial colonization and biofilm development were obtained. These results may represent an interesting option for the medical field, opening new directions for the design of modified surfaces with desired and controlled anti-biofilm properties.
Export Options
About this article
Cite this article as:
Grumezescu M. Alexandru, Essential Oils and Nanotechnology for Combating Microbial Biofilms, Current Organic Chemistry 2013; 17 (2) . https://dx.doi.org/10.2174/1385272811317020003
DOI https://dx.doi.org/10.2174/1385272811317020003 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Peptidic GnRH Receptor Antagonists
Current Medicinal Chemistry Nanoparticle-Based Therapy in Genomics
Current Drug Metabolism Learning from Multiple Classifier Systems: Perspectives for Improving Decision Making of QSAR Models in Medicinal Chemistry
Current Topics in Medicinal Chemistry Retraction Notice: Protein Identification in Sub Proteome Fractions of Breast Cancer Cells by OFFGEL-IEF and iTRAQ Labeling
Current Proteomics An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Sp/KLF Family and Tumor Angiogenesis in Pancreatic Cancer
Current Pharmaceutical Design Better Predictive Value of Cancer Antigen125 (CA125) as Biomarker in Ovary and Breast Tumors and its Correlation with the Histopathological Type/Grade of the Disease
Medicinal Chemistry Editorial (Thematic Issue: “Molecular Profiling and Ways Towards Personalized Medicine in Advanced Differentiated Thyroid Cancer”)
Current Genomics Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents
Current Pharmaceutical Biotechnology Understanding Trastuzumab Resistance in HER2 Positive Breast Cancer and Further Therapeutic Options
Current Cancer Therapy Reviews Labeling Strategies of Peptides with 18F for Positron Emission Tomography
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: The Elephant in the Room: Targeting Ras for Therapeutic Development)
Mini-Reviews in Medicinal Chemistry Targeted Therapies in Non-Small Cell Lung Cancer: Proven Concepts and Unfulfilled Promises.
Current Cancer Drug Targets Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Genotoxicity of Different Nanocarriers: Possible Modifications for the Delivery of Nucleic Acids
Current Drug Discovery Technologies BMPS and Liver: More Questions than Answers
Current Pharmaceutical Design The Osteopontin Tissue Level as a Breast Cancer Biomarker in Females After Mastectomy Measured by the Capillary Gel Electrophoresis Technique
Combinatorial Chemistry & High Throughput Screening Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin
Current Cancer Drug Targets Future Challenges for Microsomal Transport Protein Inhibitors
Current Vascular Pharmacology A Role for Milk Proteins and their Peptides in Cancer Prevention
Current Pharmaceutical Design